La comunidad científica pide redoblar esfuerzos ante el avance silencioso de las enfermedades hepáticas
During the first meeting of Group of global experts on liver estatosisHeld on June 5 and 6 at the Palau Macaya in Barcelona with the support of the Global Health Institute of Barcelona (ISGlobal), more than 100 international experts launched a blunt warning: Millions of people will remain invisible for health systems if the Early detail and care -centered care with metabolic statohepatitis (Formerly known as this alcohol without alcohol).
Common but invisible cooling
The Metabolic hepatic statosis (Masld, for its acronym in English) affects approximately 33% of adults a global level. Its most aggressive form, the Metabolic statohepatitis (MASH, for its acronym in English), it is estimated that it affects the 5% of the general population. People with Tupo 2 diabetes, obesity or other cardiometabolic risk factors present a mayor of meaning of meaning. However, a regret of its gravity, Mashy does not usually manifest symptoms to advanced stages, when it can evolve towards cirrhosis or hepilaro cancer.
In a Article published in Lancet Europe’s regional healthLeaders in hepatology and metabolic health urge health systems to Duplicate the MASH diagnostic rate before 2027. This advanced cooling, which affects silent me, is rarely detected in time, losing valuable opportunity for interventions that could improve the forecasts -reduce the health load.
The article highlights tools without invasive and intelligence -based technology that allows patient identifiers at risk from primary care, as well as the recent diagnosis. Loss Effective treatments must be accompanied by a better diagnosisThe authors affirm.
To achieve a Paradigma change in the fight against Mash and end this threat of public health in 2030The authors propose concrete actions such as the realization of routine evaluations in risk groups, the integration of liver tests in regular medical consultations, the update of reimbursement policies and the close collaboration between primary care, endocrinology, cardiology and patient associations.
«The future of the fight against Mash resides in the Anticipation: There are no patients to treat advanced alone, but early identifier to those who still do not have fibrosis. This change towards a Preventive hepatology It is key to improving the metabolic health of millions of people worldwide, ”he says Jeffrey LázaroHead of the Public Health Group of the Liver of Isglobal, center imported by the «La Caixa» Foundation, and first author of the study.
Chronic liver cooling in Spain
During the meeting there is also a brief Special for Spain, that analyzes the real situation and proposes concrete recommendations to advance a MASLD/MASH in the national health system. Spain faces a significant increase in cases of chronic hepant coolingWith a considerable impact on Mortality and health costs.
In 2021, approximate eight million people lived with Masld in Spain, a figure that is expected to increase to 12.7 million (27.6 % of the population) in 2030. In 2016, 1.8 million cases of Mash were estimated, with an increase plan That year. In addition, the direct health costs associated with this disease could more than double, from 1,480 million dollars in 2021 to 3.5 billion in 2040.
Faced with this panorama, alert Jeffrey lazarus, «we recommend a National Strategy Led by the Ministry of Health in narrow collaboration with all autonomous communities that included a MASLD registration, its incorporation into the key health inmates, mayor format for professionals, automated diagnosis in Atenonónition and the Refuera.
Change in language and care of people with detest
In parallel, more than 40 experts have published in Nature Medicine the People-Firs Heper Chartera road map to eradicate the Stigma linked to hepás diseasesThat often makes timely diagnosis and treatment difficult. Experts advocate a change towards a Person -centered language and care models that prioritize the individual Above the diagnosis label. This cove that seeks to foster respect, empathy and reduce inequalities in health, aligning with recent global initiatives that propose to rename this road map has been supported by more than 70 international organizations.
A regret of affecting more than 1.5 billion people, the Chronic liver coolness Continues largely Executed of the strategies set to deal with noncommissible cooling (ENT). A less than four months of the UN high -level meeting on, which will take place in September 2025, experts gathered in Barcelona claimed Close this historical gap And accelerate the integration of chronic liver diseases into clinical policies and practices worldwide.
«The Health promotion It is key both to prevent the appearance of steathosic liver cooling and to stop its progression. Therefore, we need public health policies oriented by an aimrass Esteve Fernández MuñozSecretary of Public Health of the Government of Catalonia (Spain), during the meeting.
References
Lázaro, Jeffrey V. et al. A call to double the diagnostic rate of steatohepatitis associated with metabolic dysfunction at risk. Lancet regional health – Europe, 2025. https://doi.org/10.1016/j.lanepe.2025.101320
Lázaro, JV, Vivancovsky Wajcman, D., Pannain, S. et al. People’s first liver letter. Nat Med (2025). https://doi.org/10.1038/s41591-025-03759-8
